| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000037017 |
| Receipt No. | R000042162 |
| Scientific Title | The study on the influence on skin by continuous intake of sub-aleurone layer residual rinse-free rice and dewed brown rice |
| Date of disclosure of the study information | 2019/06/11 |
| Last modified on | 2019/11/15 (Ver. 4) |
| Basic information | ||
| Public title | The study on the influence on skin by continuous intake of sub-aleurone layer residual rinse-free rice and dewed brown rice | |
| Acronym | The study on the influence on skin by continuous intake of sub-aleurone layer residual rinse-free rice and dewed brown rice | |
| Scientific Title | The study on the influence on skin by continuous intake of sub-aleurone layer residual rinse-free rice and dewed brown rice | |
| Scientific Title:Acronym | The study on the influence on skin by continuous intake of sub-aleurone layer residual rinse-free rice and dewed brown rice | |
| Region |
|
|
| Condition | ||
| Condition | Healthy volunteer | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose of this test is to conduct a human test on the change of skin quality after continuous intake of sub-aleurone layer residual wash-free rice and dewaxed brown rice remaining in the paste layer, and to evaluate it. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Measurement of skin function by Clreo-Pro
Fluorescent AGEs |
| Key secondary outcomes | Questionnaire survey |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | A group that consumes 150g or more of sub-aleurone layer residual rinse -free rice once a day | |
| Interventions/Control_2 | Group for consumes 150g or more of dewaxed brown rice once a day | |
| Interventions/Control_3 | Free intake group | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | [1]Japanese males and females aged 18-59 years
[2]Individuals who are healthy and are not received treatment of disease [3]Individuals whose written informed consent has been obtained [4]Individuals who can come to the designated examination date and receive the examination [5]Individuals judged appropriate for the study by the principal |
|||
| Key exclusion criteria | [1]Individuals using medical products
[2]Individuals who are or are under treatment or have a history of Impaired Glucose Tolerance,mental disabilities,sleep disorder,hypertension,diabetes,fat metabolism or the other serious dysfunctions [3]Individuals who used a drug to treat in the past 1 month (One-shot medicine of a headache, menstrual pain and a cold removes it.) [4]Individuals who have a history of serious hepatopathy, kidney damage, heart disease, lung disease,or blood disease [5]Individual who have digestive organ disease(disease of an appendix is removed) [6]Individuals whose BMI is over 30 kg/m2 [7]Individuals who are sensitive to test products or Individual with fear who causes severe allergy in a food and medical supplies [8]Individual who is pregnant or lactate [9]Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplyments of skincare in the past 3 month or will ingest those foods during the test period [10] Individuals diagnosed with photosensitivity [11]Individuals judged inappropriate for the study by the principal |
|||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | TOYO RICE CORPORATION | ||||||
| Division name | Planning and Public Relations Department | ||||||
| Zip code | 104-0061 | ||||||
| Address | 5-10-13,Ginza,Chuo-ku,Tokyo | ||||||
| TEL | 03-3572-7550 | ||||||
| seki-hiroyuki@toyo-rice.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | TOYO RICE CORPORATION | ||||||
| Division name | Planning and Public Relations Department | ||||||
| Zip code | 104-0061 | ||||||
| Address | 5-10-13,Ginza,Chuo-ku,Tokyo | ||||||
| TEL | 03-3572-7550 | ||||||
| Homepage URL | |||||||
| kawakami-marin@toyo-rice.jp | |||||||
| Sponsor | |
| Institute | TOYO RICE CORPORATION |
| Institute | |
| Department | |
| Funding Source | |
| Organization | TOYO RICE CORPORATION |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Society of Glycative Stress Research |
| Address | 5F-11,Musashino Bldg,2-13-10 Shinjuku,Shinjuku-ku,Tokyo |
| Tel | 03-6709-8842 |
| rinri-glycativestress@antiaging-bank.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 103 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042162 |